Allied Healthcare Products (NASDAQ:AHPI) and Edwards Lifesciences (NYSE:EW) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.
Analyst Recommendations
This is a summary of current recommendations and price targets for Allied Healthcare Products and Edwards Lifesciences, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Allied Healthcare Products | 0 | 0 | 0 | 0 | N/A |
Edwards Lifesciences | 2 | 6 | 13 | 0 | 2.52 |
Edwards Lifesciences has a consensus price target of $91.1569, indicating a potential upside of 3.35%. Given Edwards Lifesciences' higher probable upside, analysts plainly believe Edwards Lifesciences is more favorable than Allied Healthcare Products.
Insider and Institutional Ownership
9.5% of Allied Healthcare Products shares are held by institutional investors. Comparatively, 80.9% of Edwards Lifesciences shares are held by institutional investors. 23.8% of Allied Healthcare Products shares are held by insiders. Comparatively, 1.5% of Edwards Lifesciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Risk & Volatility
Allied Healthcare Products has a beta of -5.06, meaning that its stock price is 606% less volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500.
Profitability
This table compares Allied Healthcare Products and Edwards Lifesciences' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Allied Healthcare Products | -7.49% | -27.77% | -14.45% |
Edwards Lifesciences | 18.18% | 29.00% | 18.10% |
Earnings and Valuation
This table compares Allied Healthcare Products and Edwards Lifesciences' gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Allied Healthcare Products | $31.89 million | 0.57 | $-3,010,000.00 | N/A | N/A |
Edwards Lifesciences | $4.35 billion | 12.62 | $1.05 billion | $1.86 | 47.42 |
Edwards Lifesciences has higher revenue and earnings than Allied Healthcare Products.
Summary
Edwards Lifesciences beats Allied Healthcare Products on 10 of the 11 factors compared between the two stocks.